Kloor M | Seppälä Labhttps://www.seppalalab.org/author/kloor-m/Kloor MHugo Blox Builder (https://hugoblox.com)enWed, 01 Jan 2025 00:00:00 +0000https://www.seppalalab.org/media/logo_hu_e3f0d28ad302f75b.pngKloor Mhttps://www.seppalalab.org/author/kloor-m/Colorectal carcinogenesis in the Lynch syndromes and familial adenomatous polyposis: trigger events and downstream consequenceshttps://www.seppalalab.org/publication/moller-2025-colorectal/Wed, 01 Jan 2025 00:00:00 +0000https://www.seppalalab.org/publication/moller-2025-colorectal/A simple approach for detecting HLA-A*02 alleles in archival formalin-fixed paraffin-embedded tissue samples and an application example for studying cancer immunoeditinghttps://www.seppalalab.org/publication/witt-2023-a/Sun, 01 Jan 2023 00:00:00 +0000https://www.seppalalab.org/publication/witt-2023-a/Dominantly inherited micro-satellite instable cancer - the four Lynch syndromes - an EHTG, PLSD position statementhttps://www.seppalalab.org/publication/moller-2023-dominantly/Sun, 01 Jan 2023 00:00:00 +0000https://www.seppalalab.org/publication/moller-2023-dominantly/The Different Immune Profiles of Normal Colonic Mucosa in Cancer-Free Lynch Syndrome Carriers and Lynch Syndrome Colorectal Cancer Patientshttps://www.seppalalab.org/publication/bohaumilitzky-2022-the/Sat, 01 Jan 2022 00:00:00 +0000https://www.seppalalab.org/publication/bohaumilitzky-2022-the/Distinct Mutational Profile of Lynch Syndrome Colorectal Cancers Diagnosed under Regular Colonoscopy Surveillancehttps://www.seppalalab.org/publication/ahadova-2021-distinct/Fri, 01 Jan 2021 00:00:00 +0000https://www.seppalalab.org/publication/ahadova-2021-distinct/European guidelines from the EHTG and ESCP for Lynch syndrome: an updated third edition of the Mallorca guidelines based on gene and genderhttps://www.seppalalab.org/publication/seppala-2021-european/Fri, 01 Jan 2021 00:00:00 +0000https://www.seppalalab.org/publication/seppala-2021-european/The "unnatural" history of colorectal cancer in Lynch syndrome: Lessons from colonoscopy surveillancehttps://www.seppalalab.org/publication/ahadova-2021-the/Fri, 01 Jan 2021 00:00:00 +0000https://www.seppalalab.org/publication/ahadova-2021-the/Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndromehttps://www.seppalalab.org/publication/engel-2020-associations/Wed, 01 Jan 2020 00:00:00 +0000https://www.seppalalab.org/publication/engel-2020-associations/Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database reporthttps://www.seppalalab.org/publication/seppala-2019-lack/Tue, 01 Jan 2019 00:00:00 +0000https://www.seppalalab.org/publication/seppala-2019-lack/Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database reporthttps://www.seppalalab.org/publication/dominguez-valentin-2019-survival/Tue, 01 Jan 2019 00:00:00 +0000https://www.seppalalab.org/publication/dominguez-valentin-2019-survival/